Presented is a conceptually novel approach to oligonucleotide synthesis ref
erred to herein as dimethoxytrityl resin product anchored sequential synthe
sis (DMT PASS). The DMT PASS process is characterized by the reaction of a
3'-protected nucleoside or oligonucleotide with an excess of a nucleotide 3
'-phosphoramite or H-phosphonate which is bound to a dimethoxytrityl functi
onalized polystyrene resin, As a result, successfully coupled oligonucleoti
de product is then attached to the solid support, allowing for removal and
potential recovery of starting materials. The protected oligonucleotide pro
duct is then released and subjected to an aqueous/organic extractive purifi
cation, which serves to remove monomeric impurities. The PASS process is an
ticipated to provide for the cost-effective manufacture of oligonucleotides
on a scale which would allow for clinical development and pharmaceutical p
roduct commercialization. Herein we describe some aspects of our process de
velopment progress and discuss preliminary applications of the process to t
he synthesis of short oligodeoxyribonucleotide sequences, as well as a numb
er of challenges confronting the PASS development effort.